In addition, a recent study revealed a significant increase in the PD-L1 expression of tumor cells in the local lesions and the PD1/PD-L1 expression of inflammatory cells in an immune microenvironment of HCC patients after TACE (10). The gene discussed is PDCD1; the disease is neoplasm.